Weight Management: Clinical Trials

4 trials for Weight Management, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Recruiting 1
Phase 21Completed 1

Follow Weight Management: new trials by email Literature Review of Weight Management trials Research Report on Weight Management

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Elecoglipron, Placebo - Weight Management
Phase 3RecruitingAstraZeneca45002026-06-292026-10-13
Semaglutide in Treatment of Obesity
HD1916, semaglutide - Weight Management
Phase 3CompletedCSPC Baike (Shandong) Biopharmaceutical Co., Ltd.4622024-09-202026-04-06
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Ecnoglutide Low Dosage, Ecnoglutide Medium Dosage, Ecnoglutide High Dosage - Weight Management
Phase 3CompletedHangzhou Sciwind Biosciences Co., Ltd.6642023-04-052025-04-30
Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled Trial
Herbalife Meal Replacements - Weight Reduction, Obesity
Phase 2 / Phase 3CompletedUniversity of California, Los Angeles1002004-07-012025-05-25

Narrower conditions

Obesity (2)  ·  Overweight (1)  ·  Weight Loss (1)

Broader conditions

Body Weight (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Body Weight Changes (1)  ·  Overweight (1)

Interventions

semaglutide (1)

Sponsors

AstraZeneca (1)  ·  CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (1)  ·  Hangzhou Sciwind Biosciences Co., Ltd. (1)  ·  University of California, Los Angeles (1)

Countries

China (3)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Saudi Arabia (1)  ·  South Africa (1)  ·  South Korea (1)

Top investigators

Dr. Ania Jastreboff, MD, PhD (1)  ·  Linong Ji, Dr (1)  ·  Prof. Melanie Davies, MBChB (1)  ·  Zhaoping Li, MD, PhD (1)

Results publications

PMID 21194471, PMID 40555243

NIH funding

2025 (1)